A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(21 sites)

United States

Arizona Oncology Associates, PC - NAHOA, Prescott, Arizona

Rocky Mountain Cancer Center, Littleton, Colorado

Florida Cancer Specialists - South, Fort Myers, Florida

Florida Cancer Specialists - Lake Nona, Orlando, Florida

Florida Cancer Specialists - North, St. Petersburg, Florida